Clinical Trial Update: Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL) [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2/Phase 3 study comparing bendamustine to fludarabine in chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bendamustine (Bendamustine)
• Fludarabine (Fludarabine)

Snippet

Sponsor: WiSP Wissenschaftlicher Service Pharma GmbH | Conditions: Chronic Lymphocytic Leukemia | Phase 2, Phase 3 | Status: COMPLETED